openPR Logo
Press release

Greater awareness levels in North America is enhancing the market growth

03-22-2018 01:38 PM CET | Health & Medicine

Press release from: Medical Devices

Greater awareness levels in North America is enhancing

North America is one of the high revenue generating market for particulate respirators owing to their growing awareness levels regarding the usage of particulate respirators and increasing R&D activities in this region. Asia Pacific is considered as a lucrative market for growing opportunities of particulate respirators primarily due to the rising prevalence of respiratory disorders in countries like India. The major players are expected to find huge growth opportunities in such countries owing to the rising airborne transmitted diseases.

3M is one of the leading players of the market based on the performance and sales

Some of the key players for particulate respirators market include 3M Company, The Gerson Company, Drägerwerk AG & Co. KGaA, Honeywell International Inc., MOLDEX and Northern Safety Co., Inc. among others. New product launch is one of the key initiatives undertaken by these companies. For instance, in 2015, 3M launched organic vapor respirator cartridges, which has 3M Service Life Indicator technology that helps to direct the user for an appropriate time to change the cartridges.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/59

Government initiatives are helping spread awareness among SARS affected victims and helps in fostering market growth

Increasing prevalence of SARS is one of the major drivers impacting the particulate respirators market growth. Moreover, low cost of the product, increasing R&D activities and government initiatives undertaken in order to secure the healthcare professionals from such airborne transmission are some of the factors fueling the demand for particulate respirators. CDC is working with federal agencies, healthcare organizations and local health departments in order to spread awareness among healthcare workers for rapid recognition of person-to-person transmission of SARS. However, lack of proper awareness among people pertaining to the various types of particulate respirators available is hindering the market growth

Disposable respirators are less costly and easy to discard if damaged

On the basis of product, particulate respirators market is segmented into disposable or filtering facepiece respirators, reusable or elastomeric respirators and powered air-purifying respirators. Disposable respirators are for single-use as it gets damaged physically due to excessive resistance and sorbent exhaustion. Reusable respirators are cleaned and reused. However, the filter cartridges are disposed when they become unsuitable for use. Powered air-purifying respirators are usually attached with a battery powered blower which filters the harmful air.

Based on design, particulate respirators are of two types, half face respirators and full face respirators. Particulate respirators are used in hospital settings and also for military, laboratory and other purposes. On the basis of geography, the market is divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/particulate-respirators-market-59

Patient suffering from SARS or their surrounding people are the target population for particulate respirators

Particulate respirators are medical devices, which helps to protect one from harmful particles present in the air or dust or harmful fumes. Such harmful dust usually spread through severe acute respiratory syndrome (SARS). SARS is a respiratory syndrome commonly spread among symptomatic individuals, by person-to-person contact, or when the person sneezes or coughs, thereby infecting the nearby surfaces or through airborne transmission. Being a communicable disease, healthcare professionals and medical transport workers are at high risk to such disease as they frequently come in contact with patients suffering from SARS. Hence, Center for Disease Control and Prevention (CDC) has issued interim infection control recommendations for those high risky healthcare centers and facilities. Particulate respirators have proved to be excellent personal protector equipment in order to reduce the risk of inhaling harmful airborne particles. Particulate respirators which has the capability of filtering out 95% of airborne particles are given a 95 rating according to CDC. Likewise, respirators with 99% capability of filtering particles are given a 99 rating and so on.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Greater awareness levels in North America is enhancing the market growth here

News-ID: 989066 • Views:

More Releases from Medical Devices

Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Medical Aesthetics Market - Global Industry Insights, Trends, Outlook, and Oppor …
Medical aesthetics is an area of medicine, dealing with aesthetics, well-being, external appearance, visible skin changes, and image of the patient. Medical aesthetics involve high-technology skin care procedures that represents the fusion of beauty and healthcare services. Procedures for these involves use of advanced technologies to enhance aesthetics of the person. Demand for anti-aging products and procedures is increasing significantly, owing to increasing focus of patients to look young and
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Ophthalmic Ultrasound Imaging Systems Market - Global Industry Insights, Trends, …
Ophthalmic ultrasound imaging system is non-invasive visualization technique, which is more convenient and relatively inexpensive as compared to other techniques such as optical coherence tomography (OCT), magnetic resonance imaging (MRI), and scanning Scheimpflug. Ophthalmic ultrasound imaging systems allow imaging of anatomy and pathology involving the anterior and posterior segment of the eye. This system provides diagnostic information in conditions such as glaucoma, trauma, cysts, and neoplasms. It also allows measurement
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Eye Anatomical Model Market - Global Industry Insights, Trends, Outlook, and Opp …
Eye anatomical model refers to the type of reference models that are used to study the internal and external structures of the eye. These models are majorly used by educational institutes and optometry departments by professors to explain the internal and external anatomy of the eye in detail. These are also found to be used by professional healthcare providers such as ophthalmologists as well as opticians to educate their patients
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium Difficile Diagnostics and Treatment Market – Insights
Clostridium difficile is a disease caused by bacteria. Symptoms of the disease includes diarrhea, nausea, colon inflammation, and others. Clostridium difficile infection affects older adults, and according to Centers for Disease Control and Prevention (CDC), 2015, clostridium difficile infection is the most common healthcare-associated infection. Furthermore, frequent use of antibiotic medication is also responsible for clostridium difficile infection, as antibiotics kill normal flora (good bacteria) and allow for multiplication of

All 5 Releases


More Releases for SARS

Existing Drugs May Inhibit SARS-CoV-2 Virus
The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally. The search for effective treatments against the disease are ongoing, and one hurdle is that SARS-CoV-2, the virus that causes COVID-19, has a number of tricks up its molecular sleeve when it comes to infecting people. In a recent study published in Nature Communications Biology, researchers from
Global Severe Acute Respiratory Syndrome(SARS) Therapeutics Sales Market Report …
In this report, the global Severe Acute Respiratory Syndrome(SARS) Therapeutics market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Severe Acute Respiratory Syndrome(SARS) Therapeutics for these
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 Pharmaceutical Re …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2017”. Severe acute respiratory syndrome (SARS) is a serious, potentially life-threatening viral infection caused by virus from the Coronaviridae family. Request For Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1305521 Symptoms include cough, chills and shaking, headache, muscle aches, diarrhea, dizziness, nausea and vomiting. Risk factors include gene variation in the
Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insigh …
Market Research Hub, “Severe Acute Respiratory Syndrome Coronavirus Infection Pipeline Insights”, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection by development stage, therapy type, route of administration
Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2017, provides an overview of the Severe Acute Respiratory Syndrome (SARS) (Infectious Disease) pipeline landscape. Severe acute respiratory syndrome (SARS) is a serious, potentially